Cargando…
Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblastoma via induction of PUMA-mediated apoptosis
BACKGROUND: Glioblastoma is one of the most aggressive and common malignancies of the central nervous system in humans. Owing to the correlation of high Hsp90 expression with prognosis and clinical pathology features of diverse types of cancer, targeting Hsp90 with small-molecule inhibitors has beco...
Autores principales: | Sun, Libo, Yang, Shoujun, Chi, Guonan, Jin, Xingyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865573/ https://www.ncbi.nlm.nih.gov/pubmed/29593424 http://dx.doi.org/10.2147/OTT.S160813 |
Ejemplares similares
-
Evaluation of [(11)C]NMS-E973 as a PET tracer for in vivo visualisation of HSP90
por: Vermeulen, Koen, et al.
Publicado: (2019) -
NMS pediatría
Publicado: (2009) -
PATZ1 Induces Apoptosis through PUMA in Glioblastoma
por: Tao, Xiang, et al.
Publicado: (2022) -
NMS medicina interna /
Publicado: (2009) -
Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)